Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of metformin on long non-coding RNA expression in type 2 diabetes
IRCT20190303042903N1Phase 2Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Yasouj University of Medical Sciences. Primary endpoint: Change in long non-coding RNA expression. Started Mar 2019; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20190303042903N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190303042903N1.